Changes to Nolato's Group management

Regulatory News:

Nolato’s (STO:NOLAB) Group management will undergo a change in October 2012, when ­Nolato’s President Hans Porat – alongside his role as CEO – takes over the position of Head of Nolato Medical Business Area from Christer Wahlquist, who has decided to ­accept a position outside the Nolato Group. At the same time, Mr Porat will hand over the position of Head of Nolato Industrial Business Area to Johan Arvidsson, Managing Director of Nolato Hungary.

Christer Wahlquist has worked for Nolato since 1996, and has been Head of Nolato Medical Business Area since 2005.

"Christer has played an important part in the development of Nolato Medical, which has shown good growth under his leadership and now records annual sales of more than SEK 1 billion,” says Mr Porat. "I would like to thank Christer for his efforts, and to wish him good luck in his new role.

"Nolato Medical’s growth strategy remains unchanged. Our ambition is to be a leading global player, offering pharmaceutical and medical technology customers competitive development and production of advanced polymer products.”

Johan Arvidsson, who will take over as Head of Nolato Industrial Business Area, has worked for Nolato since 1994 and has been Managing Director of Nolato Hungary – a position that he will retain alongside his new role – for four years. Johan will also join the Group management team.

With effect from October, Nolato’s Group management team will therefore consist of President and CEO Hans Porat, CFO Per-Ola Holmström, Head of Nolato Telecom Jörgen Karlsson and Head of Nolato Industrial Johan Arvidsson.

The Nolato Group is a high-tech developer and manufacturer of polymer product systems for leading customers in medical technology, telecommunications, hygiene, automotive products and other selected industrial sectors. Nolato’s shares are quoted on the NASDAQ OMX Nordic Exchange, Stockholm Mid Cap segment, where they are included in the Industrials sector.  www.nolato.com

Nolato AB discloses the information provided herein pursuant to the Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 1.30 pm on 15 May 2011.

This information was brought to you by Cision http://www.cisionwire.com